Funding applied to Phase 1 studies for ResusixTM, a spray-dried, solvent detergent-treated human plasma, and for further development of a Multi-functional Resuscitation Fluid (MRF) that provides a...
(PRWeb July 31, 2012)
Read the full story at http://www.prweb.com/releases/20120731EntegrionWinsNavy/ContractForAlmost2M/prweb9754941.htm